The regulatory mechanism of β-eudesmol is through the suppression of caspase-1 activation in mast cell–mediated inflammatory response

References

• Holgate, S.T. The role of mast cells and basophils in inflammation. Clin. Exp. Allergy 2000, 30 Suppl 1, 28–32.
   PubMed Web of Science ®Google Scholar
• Gotis-Graham, I., Smith, M.D., Parker, A., McNeil, H.P. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann. Rheum. Dis. 1998, 57, 664–71.
   PubMed Web of Science ®Google Scholar
• Echtenacher, B., Männel, D.N., Hültner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381, 75–7.
   PubMed Web of Science ®Google Scholar
• Church, M.K., Levi-Schaffer, F. The human mast cell. J. Allergy Clin. Immunol. 1997, 99, 155–60.
   PubMed Web of Science ®Google Scholar
• Metcalfe, D.D., Baram, D., Mekori, Y.A. Mast cells. Physiol. Rev. 1997, 77, 1033–79.
   PubMed Web of Science ®Google Scholar
• Totaro, R., Passacantando, A., Russo, T., Parzanese, I., Rascente, M., Marini, C., Tonietti, G., Carolei, A. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis. Int. J. Immunopathol. Pharmacol. 2005, 18, 377–83.
   PubMed Web of Science ®Google Scholar
• Cross, M.L. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 2004, 17, 127–34.
   PubMedGoogle Scholar
• Sardella, G., Accapezzato, D., Di Roma, A., Iacoboni, C., Francavilla, V., Benedetti, G., Musto, C., Fedele, F., Bruno, G., Paroli, M. Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 2004, 17, 165–70.
   PubMedGoogle Scholar
• Di Pietro, R., Centurione, L., Sabatini, N., Bosco, D., Sancilio, S., Garaci, F., Rana, R., Cataldi, A. Caspase-3 is dually regulated by apoptogenic factors mitochondrial release and by SAPK/JNK metabolic pathway in leukemic cells exposed to etoposide-ionizing radiation combined treatment. Int. J. Immunopathol. Pharmacol. 2004, 17, 181–90.
   PubMedGoogle Scholar
• Cobb, M.H., Goldsmith, E.J. Dimerization in MAP-kinase signaling. Trends Biochem. Sci. 2000, 25, 7–9.
   PubMed Web of Science ®Google Scholar
• Lewis, T.S., Shapiro, P.S., Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74, 49–139.
   PubMed Web of Science ®Google Scholar
• Ono, K., Han, J. The p38 signal transduction pathway: activation and function. Cell. Signal. 2000, 12, 1–13.
   PubMed Web of Science ®Google Scholar
• Lee, S.H., Stehlik, C., Reed, J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276, 34495–500.
   PubMed Web of Science ®Google Scholar
• Wang, X., Wang, H., Figueroa, B.E., Zhang, W.H., Huo, C., Guan, Y., Zhang, Y., Bruey, J.M., Reed, J.C., Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington’s disease. J. Neurosci. 2005, 25, 11645–54.
   PubMed Web of Science ®Google Scholar
• Druilhe, A., Srinivasula, S.M., Razmara, M., Ahmad, M., Alnemri, E.S. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 2001, 8, 649–57.
   PubMed Web of Science ®Google Scholar
• Srinivasula, S.M., Poyet, J.L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277, 21119–22.
   PubMed Web of Science ®Google Scholar
• Stehlik, C., Lee, S.H., Dorfleutner, A., Stassinopoulos, A., Sagara, J., Reed, J.C. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 2003, 171, 6154–63.
   PubMed Web of Science ®Google Scholar
• Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430, 213–8.
   PubMed Web of Science ®Google Scholar
• Jason, G.W., Pajurkova, E.M., Suchowersky, O., Hewitt, J., Hilbert, C., Reed, J., Hayden, M.R. Presymptomatic neuropsychological impairment in Huntington’s disease. Arch. Neurol. 1988, 45, 769–73.
   PubMedGoogle Scholar
• Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., Alnemri, E.S. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 2001, 276, 28309–13.
   PubMed Web of Science ®Google Scholar
• Humke, E.W., Shriver, S.K., Starovasnik, M.A., Fairbrother, W.J., Dixit, V.M. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 2000, 103, 99–111.
   PubMed Web of Science ®Google Scholar
• Kimura, M., Kimura, I., Kondoh, T., Tsuneki, H. Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle. J. Pharmacol. Exp. Ther. 1991, 256, 18–23.
   PubMedGoogle Scholar
• Kimura, M., Nojima, H., Muroi, M., Kimura, I. Mechanism of the blocking action of beta-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles. Neuropharmacology 1991, 30, 835–41.
   PubMed Web of Science ®Google Scholar
• Tsuneki, H., Ma, E.L., Kobayashi, S., Sekizaki, N., Maekawa, K., Sasaoka, T., Wang, M.W., Kimura, I. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 2005, 512, 105–15.
   PubMed Web of Science ®Google Scholar
• Schoonbroodt, S., Legrand-Poels, S., Best-Belpomme, M., Piette, J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 1997, 321 (Pt 3), 777–85.
   PubMedGoogle Scholar
• Kimura, I. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur J Pharmacol 2005, 512, 105–115.
   PubMedGoogle Scholar
• Obara, Y. [Development of anti-dementia drugs related to neurotrophic factors]. Yakugaku Zasshi 2006, 126, 747–55.
   PubMedGoogle Scholar
• Enerbäck, L., Pipkorn, U., Granerus, G. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int. Arch. Allergy Appl. Immunol. 1986, 80, 44–51.
   PubMedGoogle Scholar
• Laitinen, L.A., Laitinen, A., Haahtela, T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 1993, 147, 697–704.
   PubMed Web of Science ®Google Scholar
• Marone, G. Mast cells in rheumatic disorders: mastermind or workhorse? Clin. Exp. Rheumatol. 1998, 16, 245–9.
   PubMedGoogle Scholar
• Papanicolaou, D.A., Wilder, R.L., Manolagas, S.C., Chrousos, G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128, 127–37.
   PubMed Web of Science ®Google Scholar
• Adwanikar, H., Karim, F., Gereau, R.W. 4th. Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain 2004, 111, 125–35.
   PubMedGoogle Scholar
• Jeong, H.J., Na, H.J., Hong, S.H., Kim, H.M. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 2003, 144, 4080–6.
   PubMed Web of Science ®Google Scholar
• Börsch-Haubold, A.G., Pasquet, S., Watson, S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 1998, 273, 28766–72.
   PubMed Web of Science ®Google Scholar
• Kim, S.J., Jeong, H.J., Park, R.K., Lee, K.M., Kim, H.M., Um, J.Y., Hong, S.H. The regulatory effect of SC-236 (4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l]benzenesulfonamide) on stem cell factor induced migration of mast cells. Toxicol. Appl. Pharmacol. 2007, 220, 138–45.
   PubMedGoogle Scholar
• Koranteng, R.D., Swindle, E.J., Davis, B.J., Dearman, R.J., Kimber, I., Flanagan, B.F., Coleman, J.W. Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin. Exp. Immunol. 2004, 137, 81–7.
   PubMedGoogle Scholar
• Faubel, S., Lewis, E.C., Reznikov, L., Ljubanovic, D., Hoke, T.S., Somerset, H., Oh, D.J., Lu, L., Klein, C.L., Dinarello, C.A., Edelstein, C.L. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007, 322, 8–15.
   PubMed Web of Science ®Google Scholar
• Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S., Flavell, R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267, 2000–3.
   PubMed Web of Science ®Google Scholar
• Chin, A.I., Dempsey, P.W., Bruhn, K., Miller, J.F., Xu, Y., Cheng, G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002, 416, 190–4.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., Inohara, N., Hernandez, L.D., Galán, J.E., Núñez, G., Janeway, C.A., Medzhitov, R., Flavell, R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416, 194–9.
   PubMed Web of Science ®Google Scholar